Funding for the insurtech sector dropped to $4.5 billion in 2023, down 44% from 2022 and 72% from its 2021 peak. Poor performance by Lemonade and frothy valuations have curtailed the appeal of the sector. However, reinsurers made investments in a record 148 deals, focusing on more advanced insurtech players.